Sobi - Swedish Orphan Biovitrum AB (publ)’s Post

Today, we celebrate #WorldHealthDay, and the efforts of the CLINSPECT-M consortium to integrate mass spectrometry-based #proteomics into systems medicine by developing of standardized start-to-finish, fit-for-purpose workflows for clinical specimens. Testing different #samplepreparation and MS protocols on two clinically relevant sample matrices (plasma and cerebrospinal fluid), the six study partners conducted two studies, implementing the most promising protocols from the first round into the second. It was a great example of how the expert-driven exchange of knowledge and best practices can result in direct practical improvements that benefit the scientific community and, ultimately, patients. And it was especially gratifying to see our iST-BCT and SP3-iST kits do so well! Read more about the study and its results: https://ow.ly/wfVw50R3o5k

CALCIO is a prospective, observational cohort study that is collecting real-world data on the use of intravascular lithotripsy (IVL) with the Shockwave Medical IVL system (Shockwave Medical, Inc.) to disrupt vascular calcifications in patients with chronic limb-threatening ischemia (CLTI). The study was initiated and is co-chaired by Dr. Raman uberoi, Prof. Peter Reimer and Prof. Christoph Binkert. CALCIO started patient enrolment on July 15, 2024, with the goal of recruiting 400 CLTI patients over the next two years. Learn more about CALCIO via CIRSE Insider! ➡️ https://t.ly/fkULP #CIRSEinsider #interventionalradiology Next Research

👨🔬Meet Dr. Ben J. Gu, Principal Science and Head of the Innate Phagocytosis Lab at the Florey Institute, University of Melbourne. Established in 2012, his lab focuses on pioneering novel diagnostic tools and therapeutic drugs for Alzheimer’s disease. We're honored to support their groundbreaking research with our INFORS HT bioreactors. "Our lab has been using INFORS HT bioreactors for nearly 10 years, from Minifors to Labfors. With their state-of-the-art design, we can easily optimize culture conditions for various applications. The stability and reliability of each batch are unmatched, allowing us to prepare our work as scheduled." - Dr. Ben Gu, Innate Phagocytosis Lab. 🔗Want to learn more about our bench-top bioreactors? https://ow.ly/F4RK50SnbTu #InforsHT #Bioreactors #ScientificInnovation #LabEfficiency #ResearchSupport #AlzheimersResearch #CustomerSatisfaction #ScientificBreakthroughs

🌎🔬 Don’t Miss AMRA Medical at ICFSR 2024! 🔬🌎 This week, the AMRA Medical team will be in attendance at the 14th annual International Conference on Frailty and Sarcopenia Research (ICFSR), where our scientists will be showcasing their latest insights into muscle composition's critical role in various health outcomes. The presentations demonstrate the utility of AMRA's MRI-based body composition analysis platform, AMRA® Researcher, in delivering novel biomarkers that describe overall muscle health. This innovative approach is transforming muscle composition research by enabling more personalized insights on function and performance. By advancing disease research in neuromuscular, metabolic diseases, and beyond, AMRA Medical continues to lead with cutting-edge MRI-powered analyses, offering more personalized insights for researchers, patients, and providers alike. Stay tuned for more updates on how we're advancing disease research with our precision imaging platform in sarcopenia and beyond! To get in touch or if you are attending and want to meet us at ICFSR, reach out to info@amramedical.com. #ICFSR2024 #AMRAMedical #MuscleComposition #ChronicKidneyDisease #Sarcopenia #precisionmedicine #neuromusculardisease #MRI #clinicalresearch

🎞 Watch the Amazing Highlights of the most recent Precision in Clinical Trials #PCTSUMMIT & Precision in Medical Devices #PMDSUMMIT that recently happened at the Hilton Boston Park Plaza on May 6th-7th, 2024. Link to Watch ➡ : https://lnkd.in/eRYsJi3u This #Summit brought together numerous #Biopharma leaders that discussed the recent wave of #Innovation that is coming to the #ClinicalTrials and #DrugDevelopment industry in 2024 and beyond. Email us at info@Precision-Globe.com to learn about our upcoming #LifeSciences Events, you can also learn more by visiting the link below: 📲 https://lnkd.in/ecp62Jy #DigitalHealth #EastCoast #LifeSciences #ClinicalDevelopment #CRO #ClinicalOperations #AI #ML #Datamanagement #Biostats #MedTech #MedicalDevices #Pharma #Biotech #Diagnostics #Therapeutics #Medicine #Patients #Oncology #RareDisease #CNS #Neurology #TherapeuticFocused #PatientRecruitment #Marketing

Still processing a lot of great discussions from the #EUMS2024. Had a very productive (and good) time with Stephen Wildhirt, M.D., Ph.D. and was really proud to see how the insights that he presented from our #firstinhuman clinical trial lead to some great session discussions (and further discussions afterwards). And then as an audience member, taking a step back and seeing how far we at AdjuCor GmbH have come and are coming nearer to bringing a cardiac support device that can AVOID blood contact to the 100,000's of patients in need. #advancedheartfailure Despite much interesting and upcoming tech that focuses on minimizing the consequences of blood contact 🩸 🩸, the benefits of avoiding it cannot be overstated. #nobloodcontact Very interesting to also have Mayo Clinic participating - a substantial add of scope to this meeting 💪 Big kudos to Prof. Dr. J. D. Schmitto, MD, PhD, MBA, FRCS(Glasg) FACS for leading an excellent conference organization and program - and the whole team of HTTG-Chirurgie Medizinische Hochschule Hannover 👏👏

📢 Excited to announce my participation in this year's annual #AACR meeting in #SanDiego! Join me and a great panel of experts, including Tony Letai and Diana Azzam, PhD, as we discuss the latest advancements in functional precision medicine. Check out the session details here: https://lnkd.in/eRrUm7FY #pharmacoscopy #snijderlab #precisionmedicine #precisiononcology #fpm Society for Functional Precision Medicine

ASIA 2024 PRECOURSES - REGISTER NOW! Researchers, Clinicians, and other SCI Professionals are invited to join us for the 2024 Annual Scientific Meeting, May 20-23 in San Juan, Puerto Rico. The conference will include three-and-a-half days of Precourses, Courses, General Sessions, Posters, and endless networking.  Precourse 1 DME and Accessibility: The Essence for Maintaining Autonomy and Independence of People with a Spinal Cord Injury A collaborative one-day workshop organized by three ASIA Committees (Americas, Rehabilitation Standards and Education) to enhance the knowledge of spinal cord injury care for any provider involved in the care of this patient population in the United States and abroad. Precourse 2 From Molecules to Movement – Scope, Utility, and Application of Biomarkers for SCI Clinical Trials and the Development of SCI Precision Medicine Spinal Cord Outcomes Partnership Endeavor (SCOPE) This pre-course is tailored for SCI clinicians, preclinical and clinical researchers as well as biomarker scientists

Hey everyone! Meet Dr. Howard Fillit, a leader in Alzheimer's research and a member of our Scientific Advisory Board. Dr. Fillit is the Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation, a Clinical Professor of Geriatric Medicine and Palliative Care at The Icahn School of Medicine, and has authored or co-authored over 300 publications. When discussing the future of Alzheimer's, Dr. Fillit shared, “This is a defining time for Alzheimer’s research with better diagnostics, a solid scientific understanding, and 120 drugs in clinical trials looking at novel treatments for Alzheimer’s disease.” Learn more about our Scientific Advisory Board: https://lnkd.in/gA3MPWPc #AlzheimersResearch #GeriatricMedicine #ClinicalResearch #AlzheimersAwareness

What were the main scientific highlights and key learnings from #EuroPCR 2024, and what should you know about impact on practice? In this short session replay, Davide Capodanno summarises his key takeaways from this year's Course ➡ https://lnkd.in/d5XsMnQW (open access). Nieves Gonzalo Nicolas Dumonteil Thomas Cuisset #interventionalcardiology #clinicaltrials #latebreakingscience #trialupdates